Trial · NCT00680745
Adverse events172
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 172
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | NASOPHARYNGITIS | Infections and infestations | Dapagliflozin 2.5mg + Glimepiride | 3 | 154 | |
| other | NASOPHARYNGITIS | Infections and infestations | Dapagliflozin 5mg + Glimepiride | 8 | 145 | |
| other | NASOPHARYNGITIS | Infections and infestations | Dapagliflozin 10mg + Glimepiride | 5 | 151 | |
| other | NASOPHARYNGITIS | Infections and infestations | Placebo + Glimepiride | 4 | 146 | |
| other | HYPERTENSION | Vascular disorders | Dapagliflozin 2.5mg + Glimepiride | 8 | 154 | |
| other | HYPERTENSION | Vascular disorders | Dapagliflozin 5mg + Glimepiride | 2 | 145 | |
| other | HYPERTENSION | Vascular disorders | Dapagliflozin 10mg + Glimepiride | 2 | 151 | |
| other | HYPERTENSION | Vascular disorders | Placebo + Glimepiride | 6 | 146 | |
| other | Hypoglycemia | Endocrine disorders | Dapagliflozin 2.5mg + Glimepiride | 11 | 154 | |
| other | Hypoglycemia | Endocrine disorders | Dapagliflozin 5mg + Glimepiride | 10 | 145 | |
| other | Hypoglycemia | Endocrine disorders | Dapagliflozin 10mg + Glimepiride | 12 | 151 | |
| other | Hypoglycemia | Endocrine disorders | Placebo + Glimepiride | 7 | 146 | |
| serious | Febrile Neutropenia | Blood and lymphatic system disorders | Dapagliflozin 2.5mg + Glimepiride | 1 | 154 | |
| serious | Febrile Neutropenia | Blood and lymphatic system disorders | Dapagliflozin 5mg + Glimepiride | 0 | 145 | |
| serious | Febrile Neutropenia | Blood and lymphatic system disorders | Dapagliflozin 10mg + Glimepiride | 0 | 151 | |
| serious | Febrile Neutropenia | Blood and lymphatic system disorders | Placebo + Glimepiride | 0 | 146 | |
| serious | ACUTE MYOCARDIAL INFARCTION | Cardiac disorders | Dapagliflozin 2.5mg + Glimepiride | 0 | 154 | |
| serious | ACUTE MYOCARDIAL INFARCTION | Cardiac disorders | Dapagliflozin 5mg + Glimepiride | 0 | 145 | |
| serious | ACUTE MYOCARDIAL INFARCTION | Cardiac disorders | Dapagliflozin 10mg + Glimepiride | 0 | 151 | |
| serious | ACUTE MYOCARDIAL INFARCTION | Cardiac disorders | Placebo + Glimepiride | 1 | 146 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00680745/events